Medici Brands Raises $250M for CPG Expansion

Medici Brands, the parent entity behind the protein-focused David Protein and the recently unveiled confectionary line HallPass, has successfully closed a substantial $250 million Series B funding round. This significant capital infusion underscores investor confidence in the company's strategy to build a diversified consumer packaged goods portfolio.

The financing was jointly led by prominent investment firms Greenoaks and Valor Equity Partners. Both firms demonstrated prior conviction in Medici Brands' potential, having participated in the company's $75 million Series A round in 2025. Their continued support highlights a strong belief in the management team's execution capabilities and the market opportunity for their brands.

Further bolstering the round were strategic investments from notable figures and firms including Peter Rahal, ICONIQ, and Imaginary Ventures. The involvement of these sophisticated investors signals a robust validation of Medici Brands' growth trajectory and its innovative approach within the competitive consumer goods sector. The influx of capital is expected to accelerate product development, expand distribution channels, and enhance marketing efforts for both existing and future brands under the Medici umbrella.

The consumer packaged goods market, particularly within the health and wellness and indulgent snack categories, has seen dynamic shifts. Consumers are increasingly seeking products that align with specific dietary needs or offer unique taste experiences. Medici Brands appears strategically positioned to capture these evolving preferences, leveraging its dual focus on functional nutrition through David Protein and novel confectionery through HallPass. The broader CPG sector is projected for steady growth, with specialized segments like plant-based proteins and premium snacks exhibiting particularly strong upward trends.

This latest funding positions Medici Brands to significantly scale its operations. The company plans to leverage the capital to enhance its supply chain efficiencies, invest in cutting-edge product innovation, and broaden its market penetration across key demographics. The expansion of HallPass, in particular, comes at a time when the global confectionery market is experiencing a resurgence, driven by demand for premium and artisanal offerings.

The strategic backing from a syndicate of experienced investors like Greenoaks and Valor Equity Partners, alongside other key players, provides Medici Brands with not only financial resources but also invaluable strategic guidance. This partnership is anticipated to be instrumental in navigating the complexities of the CPG industry and achieving ambitious expansion goals. The company's ability to attract such significant investment in a competitive funding environment speaks volumes about its market positioning and future prospects.